| Literature DB >> 27507797 |
Elise K Pasoreck1, Jin Su1, Ian M Silverman2, Sager J Gosai2, Brian D Gregory2, Joshua S Yuan3, Henry Daniell1.
Abstract
The impact of metabolic engineering on nontarget pathways and outcomes of metabolic engineering from different genomes are poorly understood questions. Therefore, squalene biosynthesis genes FARNESYL DIPHOSPHATE SYNTHASE (FPS) and SQUALENE SYNTHASE (SQS) were engineered via the Nicotiana tabacum chloroplast (C), nuclear (N) or both (CN) genomes to promote squalene biosynthesis. SQS levels were ~4300-fold higher in C and CN lines than in N, but all accumulated ~150-fold higher squalene due to substrate or storage limitations. Abnormal leaf and flower phenotypes, including lower pollen production and reduced fertility, were observed regardless of the compartment or level of transgene expression. Substantial changes in metabolomes of all lines were observed: levels of 65-120 unrelated metabolites, including the toxic alkaloid nicotine, changed by as much as 32-fold. Profound effects of transgenesis on nontarget gene expression included changes in the abundance of 19 076 transcripts by up to 2000-fold in CN; 7784 transcripts by up to 1400-fold in N; and 5224 transcripts by as much as 2200-fold in C. Transporter-related transcripts were induced, and cell cycle-associated transcripts were disproportionally repressed in all three lines. Transcriptome changes were validated by qRT-PCR. The mechanism underlying these large changes likely involves metabolite-mediated anterograde and/or retrograde signalling irrespective of the level of transgene expression or end product, due to imbalance of metabolic pools, offering new insight into both anticipated and unanticipated consequences of metabolic engineering.Entities:
Keywords: Secondary metabolism; retrograde/anterograde signalling; squalene; transgenic/transplastomic plants
Mesh:
Substances:
Year: 2016 PMID: 27507797 PMCID: PMC4980996 DOI: 10.1111/pbi.12548
Source DB: PubMed Journal: Plant Biotechnol J ISSN: 1467-7644 Impact factor: 9.803
Figure 1Chloroplast transformation vectors and characterization of transplastomic lines. (a) Schematics of the tobacco chloroplast genome, transformation vectors and probe hybridization sites with predicted sizes of hybridizing fragments in Southern blots. Top, untransformed; centre, pLD‐SQS; bottom, pLD‐FPS‐SQS. (b) Genomic DNA (0.5 μg) from independent transplastomic lines was digested with AflIII (CN lines, left) or HindIII (C lines, right) and probed with a DIG‐labelled probe specific for the trnI/trnA flanking region. (c) Total RNA (1–5 μg) was hybridized with a DIG‐labelled TrbcL probe. Northern blots were exposed to films for 15 min. (top) or 1 h. (middle), and ethidium bromide‐stained gel (bottom) is a loading control. (d) Anti‐Flag western blot of indicated amounts of total protein. FPS, FARNESYL DIPHOSPHATE SYNTHASE; SQS, SQUALENE SYNTHASE.
Figure 2Leaf and flower phenotypes of FPS/SQS plants. (a) Plants after 5 weeks in the growth chamber. (b, c) Glasshouse‐grown plants after 1 week (b, front), 3 weeks (b, back) or 5 months (c). (d) Shoot apices. (e) Aborted buds. (f–i) Phenotypes of CN (f), N (g), C (h) and WT (i) flowers. FPS, FARNESYL DIPHOSPHATE SYNTHASE; SQS, SQUALENE SYNTHASE; WT, wild‐type
Figure 3Impact of / expression on levels of cellular metabolites. (a) PCA showing clustering of quadruplicate samples from each line. (b) Boxplot showing squalene levels. (c) Heat map showing functional categories of metabolites. Each box represents one sample. (d) Graphs showing the accumulation of selected metabolites compared with WT, including aromatic amino acid derivatives (left) and TCA cycle‐related metabolites (right). Error bars indicate SEM. Abbreviations for statistical analysis are clustered in groups of three and are ordered N, CN, C. a, statistically significant increase over WT; b, statistically significant decrease relative to WT; –, difference with WT is not statistically significant. In the left panel, three letter abbreviations are those of amino acids; Phe.a, phenethylamine; Trp.a, tryptamine; Tyr.a, tyramine. FPS, FARNESYL DIPHOSPHATE SYNTHASE; PCA, principal component analysis; SQS, SQUALENE SYNTHASE; WT, wild‐type.
List of metabolites whose abundance changes at least 10‐fold compared with wild‐type (WT)
| Metabolite | Category | Family | N/WT | CN/WT | C/WT |
|---|---|---|---|---|---|
| Squalene | Secondary metabolism | Terpenoids | 154.10 | 158.57 | 158.86 |
| 3‐(2‐piperidinyl)pyridine | Secondary metabolism | Alkaloids | −1.17 | 32.16 | 31.82 |
| Pheophorbide A | Cofactors, prosthetic groups, electron carriers | Chlorophyll and haem metabolism | 1.00 | 25.52 | 2.58 |
| Gluconate | Carbohydrate | Amino sugar and nucleotide sugar | 1.55 | 24.85 | 10.42 |
| Citrate | Carbohydrate | TCA cycle | 1.13 | 14.16 | 5.41 |
| Tryptamine | Amino acid | Aromatic amino acid metabolism (PEP derived) | 1.76 | 9.35 | 13.48 |
| 4‐hydroxybutyrate (GHB) | Amino acid | Glutamate family (alpha‐ketoglutarate derived) | −1.75 | 12.54 | −1.50 |
| Tyramine | Amino acid | Aromatic amino acid metabolism (PEP derived) | −1.05 | 11.78 | 11.21 |
| Phenethylamine | Amino acid | Aromatic amino acid metabolism (PEP derived) | 1.57 | 11.11 | 11.55 |
| 1‐palmitoyl‐GPI (16:0) | Lipid | Phospholipid | 1.01 | 11.27 | 3.93 |
Statistically significant difference in the accumulation of the indicated metabolite compared with WT.
Figure 4RNA‐seq analysis of FPS/SQS plants. (a) Hierarchical clustering analysis and (b) PCA of duplicate samples. (c) Heat map showing overrepresented biological processes for up‐ and down‐regulated transcripts in each line. Indicated values are –log10 of the Benjamini adjusted p‐value. (d, e) RNA‐seq data for transcripts derived from Nicotiana tomentosiformis (Nt, cyan) and Nicotiana sylvestris (Ns, blue) genomes (upper panels, primary y‐axis) and qRT‐PCR confirmation of transcript levels (lower panels, yellow, secondary y‐axis) for transcripts that are induced (d) or repressed (e) relative to WT. In lower panels, error bars represent mean ± SEM of two biological replicates with three technical replicates each. FPS, FARNESYL DIPHOSPHATE SYNTHASE; PCA, principal component analysis; SQS, SQUALENE SYNTHASE; WT, wild‐type.
Top 20 overall most highly induced transcripts and their expression in other two transgenic/transplastomic lines, grouped by functional category. When possible, each locus includes an annotation for Nicotiana tomentosiformis (Nt) and an annotation for Nicotiana sylvestris (Ns). Values without asterisks indicate 99.9% confidence. Cells without values were not significantly changed for the indicated transcript in the indicated line
| Rank | NCBI gene ID/At number |
| N/Wild‐type (WT) | CN/WT | C/WT |
|---|---|---|---|---|---|
| Transporters | |||||
| 1 | LOC104087257/At4g12510 | Nt | 806.987 | 940.608 | 172.152 |
| LOC104242032/At4g12510 | Ns | 73.826 | 56.626 | 18.003 | |
| 4 | LOC104088673/At3g48740 | Nt | 87.235 | 201.150 | 65.779 |
| LOC104243017/At3g48740 | Ns | 148.741 | 327.890 | 72.298 | |
| 5 | LOC104115159/At3g54700 | Nt probable | 11.423 | 15.762 | |
| LOC104216800/At3g54700 | Ns probable | 10.502 | 323.984 | 299.250 | |
| 6 | LOC104086110/At5g59030 | Nt | 20.421 | 318.867 | 55.805 |
| LOC104244096/At5g59030 | Ns | 23.937 | 271.475 | 68.523 | |
| 8 | LOC104084825/At5g16530 | Nt putative | 299.984 | 48.512 | |
| LOC104249472/At5g16530 | Ns putative | 201.077 | 32.503 | ||
| 10 | LOC104086686/At1g21460 | Nt | 248.285 | 220.603 | 259.497 |
| LOC104225662/At1g21460 | Ns | 63.264 | 79.362 | 57.860 | |
| 12 | LOC104101946/At5g59520 | Nt | 32.226 | ||
| LOC104211888/At5g59520 | Ns | 13.010 | 249.781 | 15.498 | |
| 14 | LOC104096904/At5g53190 | Nt bidirectional sugar transporter | 182.521 | 140.590 | |
| LOC104241809/At5g53190 | Ns bidirectional sugar transporter | 236.357 | 107.210 | ||
| 17 | LOC104118881/At5g47560 | Nt | 37.066 | 9.426 | |
| LOC104242854/At5g47560 | Ns | 221.581 | 33.801 | ||
| Growth and development | |||||
| 2 | LOC104105402/At5g62040 | Nt | 538.996 | ||
| LOC104229471/At5g62040 | Ns | 431.913 | 14.363 | ||
| 3 | LOC104089336/At5g10625 | Nt | 115.961 | 356.184 | 16.807 |
| LOC104232534/At5g10625 | Ns | 440.531 | 12.179 | ||
| 7 | LOC104104199/At5g06720 | Nt | 20.544 | 312.576 | 80.377 |
| LOC104217681/At5g06720 | Ns | 81.758 | |||
| 13 | LOC104243032/At4g25820 | Ns | 197.748 | 242.975 | 69.681 |
| Secondary metabolism | |||||
| 9 | LOC104099208/At4g14090 | Nt | 94.367 | 272.367 | 18.904 |
| LOC104227958/At4g14090 | Ns | 9.567 | 12.620 | 4.611 | |
| 15 | LOC104104691/At4g19170 | Nt | 131.189 | 101.045 | 234.293 |
| 19 | LOC104107213/At4g15480 | Nt | 214.326 | 200.087 | 142.143 |
| Hormone | |||||
| 11 | LOC104088764/At1g75750 | Nt | 58.475 | 256.662 | 11.149 |
| Primary metabolism | |||||
| 16 | LOC104096882/At5g48850 | Nt uncharacterized/ | 38.021 | 227.743 | |
| Cytoskeleton | |||||
| 18 | LOC104116945/At1g70810 | Nt probable ADP‐ribosylation factor GTPase‐activating protein | 9.630 | 91.183 | 12.693 |
| LOC104249050/At1g70810 | Ns probable ADP‐ribosylation factor GTPase‐activating protein | 52.144 | 216.566 | 32.270 | |
| Defence | |||||
| 20 | LOC104103886/At2g38870 | Nt | 79.968 | 100.779 | 23.172 |
| LOC104231145/At2g38870 | Ns | 131.969 | 210.761 | 35.884 | |
Value reported at the 99.0% confidence level.
Top 20 overall most highly repressed transcripts and their expression in other two transgenic/transplastomic lines, grouped by functional category. When possible, each locus includes an annotation for Nicotiana tomentosiformis (Nt) and an annotation for Nicotiana sylvestris (Ns)
| Rank | NCBI gene ID/At number |
| N/Wild‐type (WT) | CN/WT | C/WT |
|---|---|---|---|---|---|
| Cell cycle | |||||
| 1 | LOC10409419/At1g30690 | Nt | −816.166 | −263.187 | −2262.789 |
| LOC10421949/At1g30690 | Ns | −493.844 | −746.213 | −666.637 | |
| 7 | LOC10408601/At5g06150 | Nt | −726.831 | −364.512 | −559.138 |
| LOC10423757/At5g06150 | Ns | −1052.573 | −524.124 | −1325.489 | |
| 10 | LOC10421173/At4g11080 | Ns | −531.236 | −317.492 | −1124.502 |
| 11 | LOC10424297/At1g44110 | Ns | −257.417 | −401.190 | −989.323 |
| 12 | LOC10409411/At3g20150 | Nt kinesin‐like | −732.380 | −361.282 | −918.263 |
| LOC10424399/At3g20150 | Ns kinesin‐like | −368.772 | −322.527 | −453.958 | |
| 13 | LOC10411222/At1g03780 | Nt | −584.023 | −504.647 | −308.380 |
| LOC10421712/At1g03780 | Ns | −915.733 | −790.737 | −694.173 | |
| 15 | LOC10410080/At2g26760 | Nt | −682.727 | −593.531 | −850.024 |
| LOC10422394/At2g26760 | Ns | −248.516 | −119.077 | −306.997 | |
| 16 | LOC10409883/At1g08560 | Nt | −654.447 | −125.074 | −298.701 |
| LOC10422292/At1g08560 | Ns | −647.369 | −163.412 | −847.873 | |
| Cell wall/cuticle | |||||
| 3 | LOC10411994/At4g22010 | Nt | −459.175 | −660.733 | −594.408 |
| LOC10423150/At4g22010 | Ns | −481.000 | −1001.534 | −1473.924 | |
| 6 | LOC10410009/At5g47500 | Nt probable | −642.662 | −370.989 | −1355.422 |
| LOC10421908/At5g47500 | Ns probable | −345.366 | −518.392 | −831.930 | |
| 19 | LOC10409611/At1g02205 | Nt | −38.939 | −91.297 | −78.052 |
| LOC10424030/At1g02205 | Ns | −199.464 | −546.898 | −799.481 | |
| Kinase | |||||
| 4 | LOC10411606/At3g51740 | Nt probably inactive leucine‐rich repeat receptor‐like protein kinase | −1446.626 | −764.462 | −457.671 |
| LOC10423705/At3g51740 | Ns probable leucine‐rich repeat receptor‐like protein kinase | −305.037 | −265.833 | −219.477 | |
| 17 | LOC10409992/At5g43020 | Nt probable inactive receptor kinase At5g67200/LRR kinase family | −168.644 | −572.847 | −841.587 |
| LOC10423543/At5g43020 | Ns probable inactive receptor kinase At5g67200/LRR kinase family | −32.928 | −96.819 | −44.635 | |
| Miscellaneous | |||||
| 18 | LOC10409693/At4g31840 | Nt | −395.968 | −118.288 | −821.479 |
| LOC10421187/At4g31840 | Ns | −343.122 | −120.464 | −623.076 | |
| 20 | LOC10412083/At5g23420 | Nt | −500.882 | −134.517 | −476.056 |
| LOC10424371/At5g23420 | Ns | −262.125 | −222.445 | −790.240 | |
| Lipid metabolism | |||||
| 2 | LOC10412153/At5g33370 | Nt GDSL esterase/lipase At5g33370‐like/GDSL‐motif esterase/lipase | −546.326 | −2106.034 | −1221.907 |
| LOC10422041/At5g33370 | Ns GDSL esterase/lipase At5g33370‐like/GDSL‐motif esterase/lipase | −79.807 | −93.596 | −224.898 | |
| Secondary metabolism | |||||
| 5 | LOC10408627/At5g66230 | Nt uncharacterized/chalcone‐flavanone isomerase | −828.169 | −136.904 | −490.657 |
| LOC10421950/At5g66230 | Ns uncharacterized/chalcone‐flavanone isomerase | −686.380 | −310.377 | −1419.234 | |
| Growth and development | |||||
| 8 | LOC10409319/At2g42840 | Nt | −1003.212 | −869.240 | −1255.300 |
| LOC10422232/At2g42840 | Ns | −486.103 | −145.233 | −302.012 | |
| DNA remodelling | |||||
| 9 | LOC10412078/At3g23890 | Nt | −615.688 | −1172.774 | −442.749 |
| LOC10424672/At3g23890 | Ns | −189.431 | −287.318 | −247.807 | |
| Cytoskeleton | |||||
| 14 | LOC10408502/At1g03470 | Nt uncharacterized/ | −688.519 | −235.486 | −866.163 |
| LOC10422085/At1g03470 | Ns uncharacterized/ | −306.668 | −252.734 | −287.424 | |